Skip to Content

October 13, 2017, 12:30 PM

High-need patients require the most attention from health care providers and the health care system, with the top 1% of patients taking up more than 20% of health care expenditures. This panel will examine what policies can optimize the care of such patients and whether systems can be designed to better serve their needs. What actions can support the spread and scale of evidence-based programs?

Panelists

  • Dave Chokshi, MD, Affiliated Faculty, NYU Wagner Clinical Associate Professor, NYU Langone School of Medicine

  • Julian Harris, MD, MBA, President, CareAllies, Sr. Vice-President for Strategic Operations, Cigna

This event was free and open to the public.

Learn more about the Health Policy and Bioethics Consortia.

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Center for Bioethics at Harvard Medical School and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.

Tags

bioethics   doctor patient relationship   health law policy   health policy and bioethics consortia